NCT05840172已完成不适用
An Open Label, Randomised, 3-way Cross-over, Single-centre, Clinical Investigation to Evaluate the Effectiveness of Benzocaine in Two NRL Condoms Compared With a Standard NRL Control Without Benzocaine in Prolonging Time to Ejaculation in Healthy Adult Men Who Feel They Ejaculate Too Quickly During Vaginal Sex
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- To determine the effectiveness of benzocaine of the Test Condom A compared with the Control NRL Condom at prolonging time to ejaculation
研究概览
简要总结
The investigation is to evaluate the effectiveness of benzocaine in two NRL condoms compared with a standard NRL control without benzocaine in prolonging time to ejaculation in healthy adult men who feel they ejaculate too quickly during vaginal sex.
详细描述
In this investigation, two NRL condoms with benzocaine paste (Test condom A and Test condom B) will be evaluated against a standard NRL male condom (Control condom) in prolonging time to ejaculation in healthy adult men who feel they ejaculate too quickly during vaginal sex.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects and their female partners have provided written informed consent.
- •Subjects and their female partners between the ages of >= 18 years and =< 60 years.
- •Subjects and their female partners must have no health condition in their medical history.
- •Subject must be sexually active having regular intercourse.
- •Subjects in a stable, monogamous, sexual relationship with the same female partner for more than or equal to 3 months.
- •Subject's female partner should already be on an established other highly effective form of non-barrier contraception, unless post-menopausal.
- •Subjects reporting a frequency of 'occasionally' to the Sexual Intercourse Self-Estimation Scale.
排除标准
- •Subject with a pregnant or breastfeeding female partner or the female partner desires to become pregnant during the clinical investigation.
- •Subject or his female partner with a current history of alcohol or drug abuse.
- •Subjects and their female partners with a history of or are suffering from anemia, coronary artery disease, impaired cardiac conduction, pulmonary disease, diabetes, and renal or hepatic disease.
- •Subjects and their female partners with a history of, suspected to have, or be at increased risk of methaemoglobinemia / complications related to ester anaesthetics which could trigger methemoglobinemia.
- •Subject and/or his female partner have a physical or psychological condition that would prevent them from following investigation procedures - including but not limited to the following:
- •urological disease,
- •ongoing significant psychiatric disorder not controlled by medication
- •history of surgery or injury to the pelvis, retroperitoneal surgery, radiotherapy, multiple sclerosis, spinal cord injury, chronic inflammation of the prostate or urethra
- •relevant previous or planned genital surgery
- •female partner that has been diagnosed with or treated for vaginal complaints (including vaginal dryness)
- •any broken skin or wounds in the genital area.
- •Subjects on medication that is contraindicated, which may affect erection.
- •Subject and/or his female partner have any medication which may affect the safety of the subject, including but not limited to benzocaine drug interactions such as cholinesterase inhibitors.
- •Subject and/or his female partner is using or intends to continue to use antibiotics of the sulphonamide type.
- •Subject with premature ejaculation, erectile dysfunction, hypo or hyperthyroidism, hypogonadism, hyperprolactinemia, ejaculatory dysfunction, haemorrhagic disorder, hepatitis B or C, human immunodeficiency virus (HIV) infection or having had penile implant surgery.
- •Subject that has been diagnosed or received treatment for PE (premature ejaculation).
- •Subjects with confirmed erectile dysfunction, hypo or hyperthyroidism, hypogonadism, hyperprolactinemia.
- •Confirmed diagnosis of male subjects with other forms of ejaculatory dysfunction.
- •Subjects that have had prior genital, prostatic or lower tract surgery.
- •Subjects with haemorrhagic disorder, hepatitis B or C, HIV infection or having had penile implant surgery, at any time in their past.
- •Either partner needed to use condoms for a specific STI protection.
- •Subjects and their female partners who have any relevant history of allergy including local anaesthetics, parabens, PABA, commercial hair dyes, paraphenylenediamine, lubricants and latex.
结局指标
主要结局
To determine the effectiveness of benzocaine of the Test Condom A compared with the Control NRL Condom at prolonging time to ejaculation
时间窗: 4 weeks for each assessment period (intervention duration)
Subjects will be recording the duration (time in minutes:seconds) from vaginal entry to ejaculation for each condom use. The outcome is evaluated by the change from baseline with the Test Condom A compared to the Control NRL Condom, over a 4-week assessment period.
次要结局
- To determine the effectiveness of benzocaine of the Test Condom B compared with the Control NRL Condom at prolonging time to ejaculation(4 weeks for each assessment period (intervention duration))
- Overall proportion of subjects with Adverse Events/Adverse Device Effects (AE/ADEs)(19 weeks)
- To determine the effectiveness of benzocaine of the Test Condom A and Test Condom B compared with the Control NRL Condom at prolonging time to ejaculation for an increase of 2, 3 and 4 minutes(4 weeks for each assessment period (intervention duration))
- To evaluate the subject's improvement at "lasting longer" for both the Test Condom A and Test Condom B compared with the Control NRL Condom(4 weeks for each assessment period (intervention duration))
- Subject's experience on the use of each type of condoms [Acceptability and In-Use Tolerability](4 weeks for each assessment period (intervention duration))
- Total clinical failure rate of each type of condoms(4 weeks for each assessment period (intervention duration))
- To evaluate the sexual pleasure when using the Test Condom A or Test Condom B compared with the Control NRL Condom(4 weeks for each assessment period (intervention duration))
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
A Clinical Investigation to Assess the Effectiveness of Benzocaine Condoms in Healthy Adult MenEjaculation DelayedNCT05255770Reckitt Benckiser Healthcare (UK) Limited
已完成
3 期
Comparison of the Effectiveness of Benzocaine gel and Lidocaine- Prilocaine cream on Pain and Anxiety Reduction due to Dental Injection in Primary TeethPain and anxiety due to anesthesia infiltration injection in pediatric dentistry.IRCT20210908052409N1Shahid Beheshti University of Medical Sciences21
已完成
不适用
A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% FormulationsVulvovaginal CandidiasisNCT01039584Padagis LLC611
尚未招募
不适用
To study the efficacy of mucoadhesive patches in reducing pain caused by elastomeric separatorsCTRI/2022/08/045049Dr Sakshi Babra
已完成
不适用
the effect of benzocaine-contained tooth paste in decreasing fixed orthodontic paiIRCT2015010120523N1Dental Research Center, Research Institute of Dental Sciences of Shahid Beheshti University of Medic33